Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 4, 2001

View Archived Issues

Spotlight on cell therapy for Parkinson's disease

NeuGene antisense compound effective against calicivirus

Encouraging preliminary results for vagus nerve stimulation in the treatment of AD

Phase II/III trials evaluate Apomate for detection of early response to chemotherapy

BTG creates new company to develop ketone body technology

deCODE maps gene linked to rheumatoid arthritis

Epimmune and Bavarian Nordic collaborate to develop HIV vaccines

PhotoCure's Metvix PDT receives European approval

New phase III trial initiated for alicaforsen in Crohn's disease

CeNeS sells chemical library of ion channel blockers to Scion

Tubulin polymerization inhibitors active against MDR tumors identified by Abbott

First approval obtained for new BPH therapeutic from GSK

Teveten HCT receives marketing approval in U.S.

LDP-392 more effective than PAF antagonists or 5-LO inhibitors in models of inflammation

Preapproval manufacturing inspection for Imavist successful

Amerimmune's novel HIV treatment completes phase Ia trial

MBI-594AN gives positive results in acne trial

Enrollment completed for eflornithine phase III pivotal trial

COBALT therapy produces dramatic antitumor effects in animals

Novel compositions and methods for gene therapy described in recent patent

Osteogenesis-promoting thiophene derivatives developed at Takeda

Potential new naturally produced anti-HIV agents with CCR5-antagonist activity

Nippon Shinyaku's new analgesics target the nociceptin receptor

Sodium channel blockers and use in epilepsy, pain, etc.

Darwin Discovery patents series of PDE7 inhibitors

Broad-spectrum antifungal agents reported by Aventis

MS&D designs compounds acting as selective 5-HT2A receptor antagonists

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...